Söndag 22 December | 07:51:35 Europe / Stockholm

Kalender

Tid*
2024-08-31 - Kvartalsrapport 2024-Q2
2024-05-01 - X-dag ordinarie utdelning ACT 0.00 DKK
2024-04-30 - Årsstämma
2024-04-13 - Bokslutskommuniké 2023
2023-08-12 - Kvartalsrapport 2023-Q2
2023-08-09 - Extra Bolagsstämma 2023
2023-05-25 - X-dag ordinarie utdelning ACT 0.00 DKK
2023-05-24 - Årsstämma
2023-04-29 - Bokslutskommuniké 2022
2022-11-18 - Extra Bolagsstämma 2022
2022-08-27 - Kvartalsrapport 2022-Q2
2022-05-25 - X-dag ordinarie utdelning ACT 0.00 DKK
2022-05-24 - Årsstämma
2022-03-19 - Bokslutskommuniké 2021
2021-06-01 - X-dag ordinarie utdelning ACT 0.00 DKK
2021-05-31 - Årsstämma
2021-03-28 - Bokslutskommuniké 2020

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorInformationsteknik
IndustriProgramvara
Decideact är verksamt inom IT-sektorn. Bolaget är specialiserat inom utveckling av molnbaserade SEM-Plattformar. Programvaran är egenutvecklad och används huvudsakligen för analys, uppföljning och för strategisk implementering. Kunderna består av företagskunder verksamma inom ett flertal sektorer som använder bolagets teknik för att fastställa och uppnå strategiska mål. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Störst verksamhet återfinns inom den europeiska marknaden.
2024-08-28 18:23:45

DecideAct A/S [ACT], company announcement no. 05-2024:

This press release constitutes inside information that DecideAct A/S is obliged to make public pursuant to the EU Market Abuse Regulation 596/2014. The information was sent for publication, through the agency of the contact persons set out below, at the time stated by the Company's news distributor, Cision, at the publication of this press release.

DecideAct receives an additional investment of DKK 1,8 million at DKK 2.75 per share equal to the volume-weighted average price (VWAP) for the last 10 trading days ending 27. August, discounted by 6.6%. The investment boosts the Company's effort to launch new AI tools for strategy already this year and further supports the effort in the North American markets.

The transaction: The investment is made by way of a directed issue and is split as follows: Jens Munch (J. Munch Holding ApS) 327,272 shares, Maximum Trust LP represented by the Chairman of the Board Peter Søndergaard Jensen 181,818 shares, CEO Flemming Videriksen (FSV 1966 Holding ApS) 72,727 shares, Co-founder Bjarni S. Jónsson (Mið ehf.) 36,363 shares and one external business partner 36,363 shares. The capital increase results in the total issuance of 654,543 new shares, corresponding to 3.1% of the share capital after the transaction, and is executed by the Board by use of the existing authorization to perform directed issues in the Company's Articles of Association.

The purpose: The capital injection will support continued growth by providing the company with additional means to scale what works, as well as further investments in AI-powered solutions and means to accelerate progress in the US and Canadian markets, thus supporting the ambition of profitability by 2025. DecideAct's mantra is to aim for the optimal path to growth with agile and fast decision-making but with caution and step-by-step.

The details:  The private investor, Jens Munch, will with the increase in share capital own 32.6% of the shares of the Company. The deadline for payment of the new shares is 14 days from today. Following the Company's receipt of payment for the shares, the total number of issued shares goes up from 20,542,579 to a new total of 21,197,122 and the share capital goes up from nominally DKK 2,054,257.90 to nominally 2,119,712.20 based upon the nominal value of 0.10 DKK/share, which corresponds to a dilution of 3.09%.

The new shares will be identical to the existing shares and an application will be made for them to be admitted to trading on Nasdaq First North Growth Market, Denmark under the existing ISIN DK0061414471 and the ticker `ACT' when the capital increase has been registered with the Danish Business Authority.

The Company will publish a company announcement when the capital increase has been registered with the Danish Business Authority.